Breaking News

Avenue Therapeutics Inc (ATXI)

NASDAQ

Add to/Remove from a Portfolio Add to Watchlist

0.135 -0.001 -0.37%

18/04 - Closed. Currency in USD ( Disclaimer )

After Hours

0.130

-0.004

-3.195%

0:23:17 - Real-time Data

Volume: 289,843
Bid/Ask: 0.131 / 0.135
Day's Range: 0.131 - 0.137

Type: Equity

Market: United States

General
Chart
- Streaming Chart
- Interactive Chart
News & Analysis
- News
Financials
Technical
Forum

ATXI Income Statement & Profits

Assess the Avenue Therapeutics Inc income statement, view the company's financial performance across their assets and liabilities. Select to view either quarterly or annual data.

Annual Quarterly

Advanced Income Statement

Collapse All

Period Ending:

2023

31/12

2023

30/09

2023

30/06

2023

31/03

Total Revenue

Revenue	-	-	-	-
Other Revenue, Total	-	-	-	-

Cost of Revenue, Total

Gross Profit

Total Operating Expenses

2.12

2.07

3.92

6.43

Selling/General/Admin. Expenses, Total	1.14	1.16	0.896	0.984
Research & Development	0.982	0.907	3.03	5.44
Depreciation / Amortization	-	-	-	-
Interest Expense (Income) - Net Operating	-	-	-	-
Unusual Expense (Income)	-	-	-	-
Other Operating Expenses, Total	-	-	-	-

Operating Income

-2.12

-2.07

-3.92

-6.43

Interest Income (Expense), Net Non-Operating

Gain (Loss) on Sale of Assets

Other, Net

-2.74

-2.58

0.093

1.17

Net Income Before Taxes

0.617

0.513

-4.02

-7.6

Provision for Income Taxes

Net Income After Taxes

0.617

0.513

-4.02

-7.6

Minority Interest

-0.928

-0.872

-0.81

-0.705

Equity In Affiliates

U.S GAAP Adjustment

Net Income Before Extraordinary Items

0.64

0.526

-4.01

-7.54

Total Extraordinary Items

Net Income

0.64

0.526

-4.01

-7.54

Total Adjustments to Net Income

Income Available to Common Excluding Extraordinary Items

0.64

0.526

-4.01

-7.54

Dilution Adjustment

-0.002

0.034

Diluted Net Income

0.642

0.492

-4.01

-7.54

Diluted Weighted Average Shares

20.9

8.2

7.76

5.56

Diluted EPS Excluding Extraordinary Items

0.031

0.06

-0.516

-1.35

DPS - Common Stock Primary Issue

Diluted Normalized EPS

0.02

0.041

-0.322

-0.842

* In Millions of USD (except for per share items)

Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com UK's comment guidelines and agree to the terms described.

I Agree

ATXI Price Commentary

Write your thoughts about Avenue Therapeutics Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

albert Garcia Blanco Jan 12, 2024 16:36

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Avenue Therapeutics, a New York-based biotechnology company, announced on January 12, 2024 that it plans to increase its workforce by 300% by the end of April 2024. The company is hiring to work on a number of new projects , including: A new treatment for lung cancer Avenue Therapeutics is developing a new treatment for lung cancer that uses a combination of immunotherapy and chemotherapy. The treatment is designed to attack cancer cells more effectively and reduce the side effects of chemotherapy. A new treatment for Alzheimer's disease Avenue Therapeutics is developing a new treatment for Alzheimer's disease that uses a combination of drugs and gene therapy. The treatment is designed to reduce the buildup of amyloid plaques in the brain, which is believed to be one of the causes of the disease. A new treatment for cystic fibrosis Avenue Therapeutics is developing a new treatment for cystic fibrosis that uses a combination of gene therapy and cell therapy. Treatment is designed to correct the genetic defect that causes the disease. These projects are unique in the world for their innovative approach to the treatment of serious diseases. If successful, they could have a significant impact on the health of patients around the world. In addition to these projects, Avenue Therapeutics is also developing new treatments for other diseases, such as multiple sclerosis, rheumatoid arthritis and diabetes. The company is committed to researching new therapies that can improve patients' lives.

1 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="233555684">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="233555684" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="233555684" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="233555684">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d51-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

FTSE 100	7,835.17	-41.88	-0.53%
DAX	17,713.25	-137.56	-0.77%
Euro Stoxx 50	4,913.75	-22.82	-0.46%
S&P 500	5,011.12	-11.09	-0.22%
Nikkei 225	37,090.50	-964.00	-2.53%
Dow Jones	37,775.38	+22.07	+0.06%
FTSE 100 Futures	7,851.5	-25.7	-0.33%

Brent Oil	86.45	-0.66	-0.76%
Crude Oil WTI	82.12	-0.61	-0.74%
Gold	2,394.20	-3.80	-0.16%
Silver	28.277	-0.103	-0.36%
Copper	4.4660	+0.0295	+0.66%
London Cocoa	10,191.00	+511.00	+5.28%
London Wheat	173.00	+0.30	+0.17%

U.K. 10Y	4.2780	+0.0040	+0.09%
U.K. 5Y	4.1960	0.0000	0.00%
U.K. 2Y	4.4770	+0.0030	+0.07%
Germany 10Y	2.4550	-0.0380	-1.52%
U.S. 10Y	4.579	-0.070	-1.51%
U.S. 5Y	4.621	-0.065	-1.38%
U.S. 2Y	4.949	-0.041	-0.82%

Lloyds Banking	50.52	-0.48	-0.94%
Vodafone Group PLC	66.000	-0.380	-0.57%
Barclays	183.34	-0.64	-0.35%
BT Group	104.30	-0.40	-0.38%
HSBC	639.50	-5.10	-0.79%
BHP Group Ltd	2,316.00	-9.00	-0.39%
Exxon Mobil	118.47	-0.16	-0.13%

Recent Quotes

	Name	Price	Chg.	Chg. %
	ATXI	0.135	-0.001	-0.37%

Market Movers

Name	Last	Chg. %	Vol.
Fonix	229.88	-4.22%	16.17M
BP	506.40	-1.17%	10.79M
Glencore	470.05	-1.04%	8.10M
HSBC	639.45	-0.80%	6.88M
Shell	2,810.0	-1.11%	1.85M
Experian	3,174.5	-0.98%	1.31M
Unilever	3,808.0	+1.01%	1.18M

Name	Last	Chg. %	Vol.
Kr1	0.77	+100000.00%	40.00K
MFE MEDIAFOREUROPE NV B	3.548	+193.47%	29.12K
SAF Holland	18.74	+179.70%	48.00
Frontline	254.00	+124.18%	10.86K
Saipem	2.22	+105.56%	4.46M
Spar Nord Bank	121.80	+77.03%	586.00
Stolt-Nielsen	474.50	+61.12%	941.00

Name	Last	Chg. %	Vol.
Casino Guichard	0.0312	-97.36%	512.42K
Wirecard	0.0190	-97.23%	0.01K
Rallye	0.0488	-96.78%	6.51K
ams OSRAM AG	0.94	-95.44%	14.15K
H Lundbeck B	32.42	-81.34%	2.89K
BioGaia B	118.70	-76.97%	0.35K
Hydrogen Refueling	4.97	-66.24%	0.03K